February 26-27, 2026
New Orleans, LA

2026 Speaking Faculty

The FULL speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.

CHAIR: Peter Hendricks, Ph.D.
CHAIR: Peter Hendricks, Ph.D.University Prof. & Heersink Endowed Chair, Dept. of Psychiatry & Behavioral Neurobiology
University of Alabama Birmingham

Peter Hendricks, Ph.D., Professor, Department of Psychiatry, University of Alabama Birmingham

Dr. Hendricks’ research centers on the development of novel and potentially more effective treatments for substance use disorders and comorbid conditions, with specific areas of focus in vulnerable populations, including individuals in the criminal justice system. He has been an active researcher in the psychedelic field since 2014, publishing population studies suggesting psychedelics may be effective in preventing and treating substance use, criminal recidivism, and psychological distress, among other outcomes, as well as a number of systemic reviews and theoretical pieces.

He is currently Principal Investigator of a pilot trial of psilocybin-facilitated psychotherapy in the treatment cocaine dependence, psilocybin-facilitated psychotherapy in the treatment of fibromyalgia, and low doses or “microdoses” of psilocybin in the treatment of demoralization. Dr. Hendricks is also PI of a NIDA-funded study of psilocybin for smoking cessation.

BIOGRAPHY
Kathryn Cunningham, Ph.D., FASPET
Kathryn Cunningham, Ph.D., FASPETProfessor & Vice Chair, Dept. of Pharmacology & Toxicology; Director, Center for Addiction Sciences & Therapeutics
University of Texas Medical Branch
Daniel Perkins, Ph.D.
Daniel Perkins, Ph.D.Head, Psychedelics Research & Therapeutics Unit/Chief Executive Officer
University of Melbourne/Neurala Biosciences
Ellen Bradley, MD
Ellen Bradley, MDAssistant Professor, Psychiatry
UCSF Weill Institute for Neurosciences
John McCorvy, Ph.D.
John McCorvy, Ph.D.Associate Prof., Cell Biology, Neurobiology & Anatomy
Medical College of Wisconsin
Gretchen Shaub, MPP
Gretchen Shaub, MPPDirector, Government Affairs
MindMed
Charles Nichols, Ph.D.
Charles Nichols, Ph.D.Professor, Department of Pharmacology and Experimental Therapeutics
LSU Health Sciences Center
Bob Discordia, Ph.D.
Bob Discordia, Ph.D.Co-Founder & Chief Executive Officer
Equulus Therapeutics
Sean Goldy, Ph.D.
Sean Goldy, Ph.D.Postdoctoral Fellow
Johns Hopkins University School of Medicine
Sam Banister, Ph.D.
Sam Banister, Ph.D.Chief Scientific Officer, Co-founder
Xylo Bio
Armin Khayatian
Armin KhayatianPrincipal
Lionheart Ventures
Ryan Gumpper, Ph.D.
Ryan Gumpper, Ph.D.Assistant Professor, Eshelman School of Pharmacy
University of North Carolina Chapel Hill
William Fantegrossi, Ph.D.
William Fantegrossi, Ph.D.Professor, Department of Pharmacology and Toxicology, College of Medicine
University of Arkansas for Medical Sciences
Josh Hardman
Josh HardmanFounder & Editor
Psychedelic Alpha
Rodrigo Machado-Vieira, MD, Ph.D.
Rodrigo Machado-Vieira, MD, Ph.D.Professor of Psychiatry, Director Experimental Therapeutics Program
University of Texas-Houston
Sandeep Nayak, MD
Sandeep Nayak, MDAssist. Prof., Dept. of Psychiatry & Behavioral Sciences; Medical Director, Johns Hopkins Center for Psychedelic & Consciousness Research
Johns Hopkins University
Junliang Hao, Ph.D.
Junliang Hao, Ph.D.Senior Vice President, Chemistry
Ignis Therapeutics
Kevin Lanzo, PharmD
Kevin Lanzo, PharmDExecutive in Residence
Lionheart Ventures
Harpreet Kaur, Ph.D.
Harpreet Kaur, Ph.D.VP Research
PharmAla
Julia Forte
Julia ForteExecutive Director, Project Management
Worldwide Clinical Trials
Mark M. Rasenick, Ph.D.
Mark M. Rasenick, Ph.D.Distinguished Professor of Physiology & Biophysics and Psychiatry/Chief Scientific Officer
University of Illinois College of Medicine/Pax Neuroscience
Grant Glatfelter, Ph.D.
Grant Glatfelter, Ph.D.Research Fellow, Designer Drug Research Unit
National Institute on Drug Abuse, National Institutes of Health
Kimberly Chew
Kimberly ChewSenior Counsel
Husch Blackwell
Steve Levine, MD
Steve Levine, MDChief Patient Officer
Compass Pathways
Anton Avanceña, Ph.D.
Anton Avanceña, Ph.D.Assistant Professor of Health Outcomes
University of Texas at Austin College of Pharmacy
Odette Hauke
Odette HaukePrincipal Consultant
Odette Alina LLC
Ryan Field, Ph.D.
Ryan Field, Ph.D.Chief Executive Officer
Kernel
William Smith, MD
William Smith, MDVice Chairman of the Board of Directors
AMR Clinical
Marion Coe, Ph.D.
Marion Coe, Ph.D.Director, Clinical Development and Postmarketing Surveillance
Pinney Associates
Bob Wold
Bob WoldFounder & Executive Director
Clusterbusters
Emmanuelle Schindler, MD, Ph.D.
Emmanuelle Schindler, MD, Ph.D.Associate Professor of Neurology
Yale School of Medicine
Raphael Leon
Raphael LeonChief Scientific Officer
NeuroMind Biopharma
Kevin Lenaburg
Kevin LenaburgPolicy Director
Clusterbusters
Manesh Girn, Ph.D.
Manesh Girn, Ph.D.Co-Founder and Chief Scientific Officer
FIVE Discovery
Florentine Barbey, Ph.D.
Florentine Barbey, Ph.D.Senior Scientist
Cumulus Neuroscience
John Huxter, Ph.D.
John Huxter, Ph.D.Global Head of EEG and Data Science
Transpharmation
Presenter to be Announced
Presenter to be Announced
Cynaptec Pharmaceuticals

The FULL speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.

About Us

Arrowhead Sci-Tech Conferences & Events offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward.

READ MORE

Contact Details

Phone:
+1 866-945-0263

Email:
enquiries@arrowheadpublishers.com

Organized By